3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1/2
1
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
20
Carcinoma, Hepatocellular
8
Stomach Neoplasms
6
Multiple Myeloma
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
4
Endometrial Neoplasms
4
Small Cell Lung Carcinoma
3
Recurrence
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Melanoma
3
Febrile Neutropenia
3
Waldenstrom Macroglobulinemia
2
Venous Thromboembolism
2
Skin Neoplasms
2
Pancreatic Neoplasms
2
Pancreatic Cancer Non-resectable
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hepatitis B
2
Hematologic Neoplasms
2
Gastric / Gastroesophageal Junction Adenocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Biliary Tract Neoplasms
2
Anemia
2
Interventions
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Not yet recruiting
×
Cytokine Release Syndrome
×
Clear all
NCT07609940
2026-05-27
POPLIN
Regeneron Pharmaceuticals
Phase 4
Not yet recruiting
30 enrolled